News

PRESS RELEASE: THE PERSHING SQUARE SOHN PRIZE AWARDED TO FIVE EMERGING LEADERS IN CANCER RESEARCH

June 4th, 2024 / THE PERSHING SQUARE FOUNDATION

THE PERSHING SQUARE SOHN PRIZE AWARDED TO FIVE EMERGING LEADERS IN CANCER RESEARCH The Pershing Square Foundation Has Committed More Than $43 Million to 71 Scientists in the Greater New York Area to Support High-Risk, High-Reward Cancer Research NEW YORK, JUNE 4, 2024 (Business Wire) – The Pershing Square Sohn Cancer Research Alliance today announced … Continued

Read More

PRESS RELEASE: The Pershing Square Sohn Cancer Research Alliance Is Now Accepting Applications for its 2024 Prize for Rising Leaders in Cancer Research

September 25th, 2023

THE PERSHING SQUARE SOHN CANCER RESEARCH ALLIANCE IS NOW ACCEPTING APPLICATIONS FOR ITS 2024 PRIZE FOR RISING LEADERS IN CANCER RESEARCH NEW YORK, SEPTEMBER 25, 2023 (The Pershing Square Foundation, Business Wire) — The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for the 2024 Pershing Square Sohn Prize for … Continued

Read More

PRESS RELEASE: The Pershing Square Sohn Cancer Research Alliance Celebrates Its 10th Anniversary; Annual $5.25M Pershing Square Sohn Prize Awarded to Seven Innovators

May 16th, 2023

Read More

Breaking New Ground With Blood Cancers Through the Lens of Splicing Factor Mutations

March 21st, 2023 / ICAHN SCHOOL OF MEDICINE AT MT. SINAI

Icahn School of Medicine at Mt. Sinai – Recent work with induced pluripotent stem cells has helped uncover complex mechanisms in myelodysplastic syndrome and acute myeloid leukemia for the first time. This discovery could pave the way for improving current treatments, or even for finding new ones. A decade ago, somatic mutations—those that occur after … Continued

Read More

Colorectal cancer tumors both helped and hindered by T cells

July 25th, 2022 / EUREKALERT / THE ROCKEFELLER UNIVERSITY

Colorectal tumors are swarming with white blood cells, but whether these cells help or hinder the cancer is hotly debated. While some studies have shown that white blood cells heroically restrict tumor growth and combat colorectal cancer, equally compelling evidence casts the white blood cells as malignant co-conspirators—bolstering the tumor and helping it spread. Now, … Continued

Read More

PRESS RELEASE: THE PERSHING SQUARE SOHN CANCER RESEARCH ALLIANCE AWARDS $4.2M TO SEVEN EMERGING TRAILBLAZERS IN CANCER RESEARCH

June 7th, 2022 / The Pershing Square Sohn Cancer Research Alliance

THE PERSHING SQUARE SOHN CANCER RESEARCH ALLIANCE AWARDS $4.2M TO SEVEN EMERGING TRAILBLAZERS IN CANCER RESEARCH The Pershing Square Sohn Prize Has Committed More Than $35 Million to 59 Scientists in the Greater New York Area to Support Bold Cancer Research NEW YORK, JUNE 7, 2022 (Business Wire) – The Pershing Square Sohn Cancer Research … Continued

Read More

Scientists Discover Gene Mutation That Signals Aggressive Melanoma

April 7th, 2022 / MOUNT SINAI HEALTH SYSTEM

Newswise — New York, NY (April 6, 2022)— Mutation of a gene called ARID2 plays a role in increasing the chance that melanoma, a deadly skin cancer, will turn dangerously metastatic, Mount Sinai researchers report. The findings suggest that patients whose melanoma tumors have an ARID2 mutation may have a more aggressive cancer and may need to be treated … Continued

Read More

HIV drug shows promise against metastatic cancer

April 5th, 2022 / Alice McCarthy, THE HARVARD GAZETTE

A drug widely used in HIV therapy has shown to stop disease progression in 25 percent of patients with fourth-line metastatic colorectal cancer. Findings from the trial, published in Cancer Discovery, raise the possibility of an unexpected promising direction in cancer treatment, not just colorectal cancer. The drug used in the study was lamivudine, a reverse transcriptase inhibitor. … Continued

Read More